Collaborative Efforts and Reports. (a) The Parties agree that the successful execution of the Research Program will require the collaborative use of both Parties' areas of expertise. The Parties shall keep the RC fully informed about the status of the portions of the Research Program they respectively perform. In particular, without limitation, each Party shall furnish to the RC quarterly written reports within thirty (30) days after the end of each quarterly period, describing the progress of its activities in reasonable detail, including (x) a summary of Project Data from ongoing Research Projects, (y) a summary of uses of Project Data and (z) a description of Project Data Sets from [Confidential Treatment Requested] (b) Scientists at CURAGEN and BIOGEN shall cooperate in the performance of the Research Program and, subject to any confidentiality obligations to third parties, shall exchange information and materials (including BIOGEN Proprietary Material) as necessary to carry out the Research Program, subject to the provisions of Section 4. Each Party will attempt to accommodate any reasonable request of the other Party to send or receive personnel for purposes of collaborating or exchanging information under the Research Program. Such visits and/or access will have defined purposes and be scheduled in advance. The requesting Party will bear the reasonable travel and lodging costs of any such personnel. (c) CURAGEN will give written notice to BIOGEN and the RC upon completion of the Project Data Set from each Research Project. "Completion" of a Project Data Set shall occur upon generation of all QEA/GeneCalling data or MIM/PathCalling data from a Research Project as contemplated by the Research Plan.
Appears in 3 contracts
Sources: Research and Option Agreement (Curagen Corp), Research and Option Agreement (Curagen Corp), Research and Option Agreement (Curagen Corp)